General Information of Drug Therapeutic Target (DTT) (ID: TTG6VD5)

DTT Name Monocarboxylate transporter 4 (SLC16A3)
Synonyms Solute carrier family 16 member 3; MCT4; MCT 4
Gene Name SLC16A3
DTT Type
Literature-reported target
[1]
BioChemical Class
Major facilitator
UniProt ID
MOT4_HUMAN
TTD ID
T31788
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MGGAVVDEGPTGVKAPDGGWGWAVLFGCFVITGFSYAFPKAVSVFFKELIQEFGIGYSDT
AWISSILLAMLYGTGPLCSVCVNRFGCRPVMLVGGLFASLGMVAASFCRSIIQVYLTTGV
ITGLGLALNFQPSLIMLNRYFSKRRPMANGLAAAGSPVFLCALSPLGQLLQDRYGWRGGF
LILGGLLLNCCVCAALMRPLVVTAQPGSGPPRPSRRLLDLSVFRDRGFVLYAVAASVMVL
GLFVPPVFVVSYAKDLGVPDTKAAFLLTILGFIDIFARPAAGFVAGLGKVRPYSVYLFSF
SMFFNGLADLAGSTAGDYGGLVVFCIFFGISYGMVGALQFEVLMAIVGTHKFSSAIGLVL
LMEAVAVLVGPPSGGKLLDATHVYMYVFILAGAEVLTSSLILLLGNFFCIRKKPKEPQPE
VAAAEEEKLHKPPADSGVDLREVEHFLKAEPEKNGEVVHTPETSV
Function
Catalyzes the rapid transport across the plasma membrane of many monocarboxylates such as lactate, pyruvate, branched-chain oxo acids derived from leucine, valine and isoleucine, and the ketone bodies acetoacetate, beta-hydroxybutyrate and acetate. Proton-linked monocarboxylate transporter.
KEGG Pathway
Central carbon metabolism in cancer (hsa05230 )
Reactome Pathway
Proton-coupled monocarboxylate transport (R-HSA-433692 )
Pyruvate metabolism (R-HSA-70268 )
Basigin interactions (R-HSA-210991 )

The Drug Transporter (DTP) Role of This DTT

DTT DTP Name Monocarboxylate transporter 4 (SLC16A3) DTP Info
Gene Name SLC16A3
1 Investigative Drug(s) Transported by This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Milchsaure DM462BT Pruritus EC90 Investigative [2]
------------------------------------------------------------------------------------

References

1 High expression of monocarboxylate transporter 4 predicts poor prognosis in patients with lung adenocarcinoma. Oncol Lett. 2017 Nov;14(5):5727-5734.
2 The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. Biochem J. 2000 Aug 15;350 Pt 1:219-27.